Clinical Trials Logo

Stomach Ulcer clinical trials

View clinical trials related to Stomach Ulcer.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05656092 Not yet recruiting - Gastric Ulcer Clinical Trials

A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer

Start date: January 2023
Phase: Phase 3
Study type: Interventional

A multicenter, randomized, double-blind, active-controlled, phase III study to evaluate the efficacy and safety of HIP0612 in patients with gastric ulcer.

NCT ID: NCT05526339 Not yet recruiting - Gastric Cancer Clinical Trials

HFNO Combined With NPA Reduces Hypoxia During Sedated Gastrointestinal Endoscopy In Obese Patients

Start date: September 2022
Phase: N/A
Study type: Interventional

Obesity is associated with adverse airway events including desaturation during deep sedation. Previous studies have suggested that high-flow nasal oxygenation may be superior to regular (low-flow) nasal cannula for prevention of hypoxia during Sedated Gastrointestinal Endoscopy in non-obesity patients. The prerequisite of high-flow nasal oxygenation is keeping airway patency. Our pervious study demonstrated that nasopharyngeal airway has the similar efficacy of jaw-lift. In present study we aimed to determine whether high-flow nasal oxygenation combined with nasopharyngeal airway could reduce the incidence of hypoxia during Sedated Gastrointestinal Endoscopy in obese patients.

NCT ID: NCT05448001 Not yet recruiting - Gastric Ulcer Clinical Trials

Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 in Patients With Gastric Ulcer

Start date: August 15, 2022
Phase: Phase 3
Study type: Interventional

A Multi-center, Randomized, Double-Blind, Active-Controlled, Parallel Group, Phase III Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 in Patients with Gastric Ulcer

NCT ID: NCT04885751 Not yet recruiting - Clinical trials for Rheumatoid Arthritis

Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy

CEERS
Start date: June 1, 2021
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the efficacy of eupatilin on the prevention of gastroenteropathy in patients with NSAIDs and low dose steroid by comparing with rebamipide.

NCT ID: NCT02689583 Not yet recruiting - Gastritis Clinical Trials

A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection

Start date: March 2016
Phase: N/A
Study type: Interventional

Since the discovery of Helicobacter pylori (H. pylori), many studies have been carried out with the goal of improving H. pylori eradication and therapies have changed from single-antibiotic treatments to the current multi-antibiotic treatments. However, the eradication rate of H. pylori is still less than 80%. The reasons for this low eradication rate are likely to be multi-factorial, including the reduced activity of antimicrobial drugs, poor patient compliance or micro-environment in stomach. In this study, to obtain the higher eradication of H. pylori and discover the different mechanism between the current infection and refractory infection of H. pylori, it is necessary to perform a prevalence survey for eradication of H. pylori based on the results from isolation of H. pylori strains, antibiotic susceptibility testing, CYP2C19 gene polymorphism, drug resistance gene sequencing and 16SrRNA sequencing.